Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt’s lymphoma anti-tumor activity
暂无分享，去创建一个
M. Firth | Paul D. Smith | Kate F. Byth | S. Green | A. Logié | S. Critchlow | L. Mooney | Haihong Zhong | Clare M. Murray | F. Michopoulos | M. Revill | N. Whalley | L. Hopcroft | N. Curtis | A. Benjamin | Nicky Whalley | K. Byth | Lorna Hopcroft